IMGUIDE - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79167250
Serial Number
79167250
Registration Number
4911442
Word Mark
IMGUIDE
Status
700 - Registered
Status Date
2016-03-08
Filing Date
2015-01-05
Registration Number
4911442
Registration Date
2016-03-08
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2015-12-22
Law Office Assigned Location Code
L20
Employee Name
VAGHANI, MAYUR C
Statements
Goods and Services
Bacterial preparations other than for medical or veterinary use; biological preparations, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents for scientific purposes other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, namely, chemical preparations for scientific purposes, chemical preparations for use in industry other than for medical or veterinary purposes; chemicals comprising glycolipid structure, namely, glycolipid for use in pharmaceutical preparations; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; lipopolysaccharide; preparations of microorganisms, namely, cultures of microorganisms, other than for medical and veterinary use
Goods and Services
Adhesive bands for medical purposes; adhesive plasters for medical purposes; adhesive tapes for medical purposes; adjuvants for medical purposes; bacterial poisons; bacterial preparations for medical or veterinary use; bacteriological preparations for medical or veterinary use; biological preparations for medical purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; biological preparations for veterinary purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; capsules for medicines in the nature of capsules containing medicine for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for medical purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical preparations for veterinary purposes, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations, namely, for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; chewing gum for medical purposes; collyrium; medicated compresses; cultures of microorganisms for medical and veterinary purposes; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical preparations for the prevention of the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; Immunomodulators, namely, lipopolysaccharides, toll-like receptor (TLR) ligands, cyclic dinucleotide, bestatin in the nature of Ubenimex pidotimod as an immunostimulant, levamisole hydrochloride, cyclooxygenase inhibitor, prostaglandin receptor antagonist, prostaglandin receptor agonist, Thymic stromal lymphopoietin (TSLP) production inhibitor, adenylate cyclase inhibitor, omega-3 fatty acid, peroxisome proliferator-activated receptor (PPAR) agonist, dopamine receptor antagonist, dopamine receptor agonist, histamine receptor agonist, histamine receptor antagonist, serotonin receptor agonist, serotonin receptor antagonist, vasopressin receptor antagonist, vasopressin receptor agonist, muscarine receptor antagonist, muscarine receptor agonist, adrenergic receptor antagonist, adrenergic receptor agonist, angiotensin receptor agonist, GABA receptor agonist, thrombin receptor antagonist, thrombin receptor agonist, opioid receptor agonist, Adenosine diphosphate (ADP) receptor agonist, leukotriene receptor antagonist, leukotriene receptor agonist, melatonin receptor agonist, somatostatin receptor agonist, cannabinoid receptor agonist, sphingosine-1 phosphate receptor agonist, metabotropic glutamate receptor agonist, phospholipase A2 inhibitor, TGF-ß production inhibitor, and Th2 cytokine inhibitor all for the treatment and prevention of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; immunosuppressive agent, namely, pharmaceutical preparations in the nature of lipopolysaccharide, toll-like receptor (TLR) ligands, cyclic dinucleotide, bestatin in the nature of Ubenimex pidotimod as an immunostimulant, levamisole hydrochloride, cyclooxygenase inhibitor, prostaglandin receptor antagonist, prostaglandin receptor agonist, Thymic stromal lymphopoietin (TSLP) production inhibitor, adenylate cyclase inhibitor, omega-3 fatty acid, peroxisome proliferator-activated receptor (PPAR) agonist, dopamine receptor antagonist, dopamine receptor agonist, histamine receptor agonist, histamine receptor antagonist, serotonin receptor agonist, serotonin receptor antagonist, vasopressin receptor antagonist, vasopressin receptor agonist, muscarine receptor antagonist, muscarine receptor agonist, adrenergic receptor antagonist, adrenergic receptor agonist, angiotensin receptor agonist, GABA receptor agonist, thrombin receptor antagonist, thrombin receptor agonist, opioid receptor agonist, Adenosine diphosphate (ADP) receptor agonist, leukotriene receptor antagonist, leukotriene receptor agonist, melatonin receptor agonist, somatostatin receptor agonist, cannabinoid receptor agonist, sphingosine-1 phosphate receptor agonist, metabotropic glutamate receptor agonist, phospholipase A2 inhibitor, TGF-ß production inhibitor, and Th2 cytokine inhibitor all for the treatment and prevention of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; lotions for pharmaceutical purposes for skin, mucosal membrane, and body; lotions for veterinary purposes for skin, mucosal membrane, and body; medicated lozenges for pharmaceutical purposes; medical plasters; medicinal drinks; medicines for dental purposes; medicines for human purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; medicines for veterinary purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; mouthwashes for medical purposes; ointments for pharmaceutical purposes, namely, vaccines; oral vaccine preparations; medicated pastilles for pharmaceutical purposes; petroleum jelly for medical purposes; pharmaceutical preparations for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for skin care; pomades for medical purposes; poultices; Pharmaceutical preparations for therapy of immunity for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; preparations of microorganisms for medical and veterinary purposes the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; siccatives for medical purposes; sticking plasters for medical purposes; syrups for pharmaceutical purposes for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; therapeutic drug for therapy of immunity, namely, vaccines; tissues impregnated with pharmaceutical lotions for the prevention and treatment of infectious disease, cancer, allergy, autoimmune disease and other disease related with immunity; vaccine adjuvants; vaccine preparations; vaccines; vaccines against influenza; vaccines against pneumococcal infections; vaccines for cattle; vaccines for dogs; vaccines for horses; vaccines for human or animal; vaccines for human use; vaccines or preparations used in the treatment of cancer; veterinary vaccines
Translation of Words in Mark
The wording "IMGUIDE" has no meaning in a foreign language.
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2015-06-24
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-06-24
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
NITTO DENKO CORPORATION
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1252031
International Registration Date
2015-01-05
International Publication Date
2015-06-18
International Renewal Date
2025-01-05
Auto Protection Date
2016-12-18
International Status
001 - Request for extension of protection established
International Status Date
2015-06-18
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2015-06-18SN ASSIGNED FOR SECT 66A APPL FROM IB
2015-06-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2015-06-24ASSIGNED TO EXAMINER
2015-06-24NON-FINAL ACTION WRITTEN
2015-06-25NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2015-06-25REFUSAL PROCESSED BY MPU
2015-06-25NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2015-06-30APPLICATION FILING RECEIPT MAILED
2015-07-11REFUSAL PROCESSED BY IB
2015-08-28TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-09-13ASSIGNED TO LIE
2015-09-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-09-21TEAS/EMAIL CORRESPONDENCE ENTERED
2015-10-13FINAL REFUSAL WRITTEN
2015-10-14FINAL REFUSAL MAILED
2015-10-26TEAS REQUEST FOR RECONSIDERATION RECEIVED
2015-10-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-10-27TEAS/EMAIL CORRESPONDENCE ENTERED
2015-11-17APPROVED FOR PUB - PRINCIPAL REGISTER
2015-11-18LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-12-02NOTICE OF PUBLICATION
2015-12-16NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2015-12-16NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2015-12-22PUBLISHED FOR OPPOSITION
2016-01-04NOTIFICATION PROCESSED BY IB
2016-03-08REGISTERED-PRINCIPAL REGISTER
2016-06-08FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2016-06-20FINAL DISPOSITION PROCESSED
2016-06-20FINAL DISPOSITION NOTICE SENT TO IB
2016-07-09FINAL DECISION TRANSACTION PROCESSED BY IB